Shareholder Primacy cover image

Legal and financial questions of Pfizer-Novo-Metsera

Shareholder Primacy

00:00

Why Novo's Bid Looked Financially Superior

Hosts compare Novo's higher cash and CVR offer to Pfizer's and discuss absolute valuation differences.

Play episode from 07:54
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app